Mesoporous structured MnSiO 3 @Fe 3 O 4 @C nanoparticles (NPs) were prepared via a facile and efficient strategy, with negligible cytotoxicity and minor side efforts. The as-prepared MnSiO 3 @Fe 3 O 4 @C NPs hold great potential in serving as pH-responsive T 1 -T 2 * dual-modal magnetic resonance (MR) imaging contrast agents. The released Mn 2+ shortened T 1 relaxation time, meanwhile the superparamagnetic Fe 3 O 4 enhanced T 2 contrast imaging. The release rate of Mn ions reaches 31.66% under the condition of pH=5.0, which is similar to tumor microenvironment and organelles. Cytotoxicity assays show that MnSiO 3 @Fe 3 O 4 @C NPs have minor toxicity, even at high concentrations. After intravenous injection of MnSiO 3 @Fe 3 O 4 @C NPs, a rapid contrast enhancement in tumors was achieved with a significant enhancement of 132% after 24 h of the administration. Moreover, a significant decreasement of 53.8% was witnessed in T 2 MR imaging signal. It demonstrated that MnSiO 3 @Fe 3 O 4 @C NPs can act as both positive and negative MR imaging contrast agents. Besides, owing to the pH-responsive degradation of mesoporous MnSiO 3 , MnSiO 3 @Fe 3 O 4 @C NPs can also be used as potential drug systems for cancer theranostics.
I. INTRODUCTION
The ultra-sensitive imaging is crucial for early diagnosis of cancer. Magnetic resonance (MR) imaging is a vital three-dimensional imaging technology means based on the relaxivity of protons within the tissues among common molecular imaging techniques, containing computed tomography (CT), positron emission tomography (PET), fluorescence optical imaging (FOI), ultrasonic imaging (US), and so on [1] [2] [3] . It can offer the three-dimensional reconstruction images of tissues at a high spatial/temporal resolution without penetration depth limitation as a non-invasive diagnostic tool [3] [4] [5] . It also has no radiation damage to normal tissues. Especially, MR imaging demands contrast agents (CAs) to improve the sensitivity of diagnostic imaging, due to the slight difference in relaxation time between pathological tissue and normal tissue. Generally, CAs make a diminished impact on relaxation time of pro-tons to modulate the MR signal [6] . Two categories of materials were applied to enhance the signal-noise ratio of MR signals at present. Paramagnetic gadolinium (Gd)-based compounds acted as T 1 CAs to drop the longitudinal relaxation time of protons, which provided a positive contrast to enhance the resolution and sensitivity [7, 8] . Superparamagnetic iron oxide NPs with strong saturation magnetization were served as T 2 CAs to achieve histopathologic diagnosis [9] . Nevertheless, Gd-based MR imaging CAs pervasively have the drawback of inevitably intrinsic toxicity and short blood circulation time [10] . It caused great side effects on kidneys and other organs [11] . Superparamagnetic T 2 CAs take a negative contrast owing to lowered MR signal. Evident defacts of calcification, bleeding, and the susceptibility artifacts restricted the clinical application to certain extent [7, 12] . Taken together, all CAs now available have ineluctable defact and restrictions. Some dual-modal CAs were designed to improve the resolution and sensitivity of MR imaging through offering integrated imaging information simultaneously [13, 14] . It contributed to concurrently achieving accurate diagnosis (T 1 * -weighted signal) and detection of lesions (T 2 * -weighted signal) [15] . Since the MRI signal in-creases with the aggregation of CAs in abnormal tissues, there is a major trend for nano-sized contrast agents because of the enhanced permeability and retention effect. The pH-responsive NPs are beneficial to achieve specific imaging of tumor tissue owing to the common phenomenon of acidic tumor microenvironment [16] . With consideration of these, Mn 2+ with strong magnetic moment may be a great alternative. Since the relaxivity can be largerly increased in response to the interaction between the released Mn 2+ and binding proteins, Mnbased systems possess tremendous advantages on contrast amplification among all paramagnetic and magnetic contrast agents [17] [18] [19] . And paramagnetic Mn
2+
can play a role in shortening relaxation time of T 1 and T 2 at the same time. It is a valuable contrast agent for MR imaging [20] [21] [22] .
In be used as a potential drug carrier for cancer theranostics. The morphology and particle size of the SiO 2 are not only related to the feed ratio of ammonia, TEOS, and deionized water, but also related to the reaction temperature and time. Uniform and monodispersed SiO 2 nanosphere is controlled by continuously adjusting the above experimental factors to keep a mean size of 12 nm. In order to ensure that the solid state SiO 2 core was completely converted to mesoporous MnSiO 3 after chemical etching, we have set up a series of control groups to determine the optimal experimental conditions. We first perform 6-group experiments to determine reaction time (4 h), then another 3-group experiments were performed to determine the reaction temperature (180 o C). stretching of the C=C and the vibration of the C=O, which root in the carboxyl functional group on the carbon layer [27, 28] . MnSiO 3 @Fe 3 O 4 @C NPs have a distinct absorption peak at 1019 cm −1 , which corresponds to the Si-O of MnSiO 3 . Raman spectroscopy (FIG. 3(c) (FIG. 4(c) ). By analysis of the Fe 2p spectrum (FIG. 4(d) ), binding energies of 710 eV (Fe 2p 3/2 ) and 724 eV (Fe 2p 1/2 ) are attributed to the Fe 3 O 4 connected to the carbon layer [34, 35] . Binding energies of 711.3 and 724.6 eV correspond to Fe 2+ of Fe 3 O 4 [32, 33] . The C 1s spectrum (FIG. 4(e) ) has three different components at binding energies of 284.5, 286.3, and 288.5 eV, corresponding to C-C, C-O, and C=O, respectively [34] . The C=O bond demonstrates the 
B. pH-responsive MR imaging
We performed the release experiment of Mn ions from 
imaging became brighter and T 2 imaging became darker with the same ion molarity. It demonstrates that MnSiO 3 @Fe 3 O 4 @C NPs possess excellent pH responsiveness which can be used as both positive contrast agent and negative contrast agent. Mesoporous MnSiO 3 is corroded and degraded into Mn 2+ under acidic condition, resulting in an increase in the number of water molecules within the core. This result increases the interaction between Fe 3 O 4 and water molecules, favoring the contrast agents to modulate the MR signal, thereby en- [26] . The mesoporous MnSiO 3 has the potential to become an excellent drug carrier.
C. Cytotoxicity test
The contrast agents demand for great biocompatibility, therefore careful evaluation of the cytotoxicity of the prepared [36] , excreted through the kidneys. In addition, Mn element is a basic element of the organism, MnSiO 3 @Fe 3 O 4 @C NPs are usually stable in the neutral blood environment and normal tissues [37] . 
D. MR imaging in vivo
Tumor-bearing mice were randomly selected to be intravenously injected certain dose of MnSiO 3 @Fe 3 O 4 @C NPs (3 mg/kg Mn) to evaluate the effects of T 1 -T 2 * dual-modal MR imaging by a 3T MR scanner. According to the data of pre-injection and after administration of MnSiO 3 @Fe 3 O 4 @C at 24 h collected from kindey, MR imaging contrast effects of the corresponding T 1 and T 2 imaging were obtained (FIG. 8(a) ). It can be clearly observed that after 24 h of injection of contrast agent, the T 1 imaging shows a significant contrast enhancement and is obviously brighter, while T 2 * -weighted image is significantly darker because of the excellent acid sensitivity of MnSiO 3 @Fe 3 O 4 @C NPs (FIG. 8(b) ). The cause for the phenomenon is that the particle size of MnSiO 3 @Fe 3 O 4 @C NPs is much larger than 10 nm. These NPs are usually absorbed by the liver kupffer cells and cleared by RES to vitro [38] [39] [40] . The Mn ions released by MnSiO 3 @Fe 3 O 4 @C NPs under acid conditions are excreted by the kidneys. In consideration of the T 1 -T 2 * dual-modal MR imaging contrast agents, MnSiO 3 @Fe 3 O 4 @C NPs have capability to shorten the relaxation time of water protons, and we quantified the imaging effect of a defined area of the tumor. Quantitative analysis displayed that the T 1 signal intensity increased approximately by 32% after intravenous injection 24 h compared with the preinjection (FIG. 8(c) ). Meanwhile, there was a decrease of T 2 signal intensity to 53.8% (FIG. 8(d) ). It proved that MnSiO 3 @Fe 3 O 4 @C NPs have a unique dual-mode MR imaging effect to enhance T 1 -T 2 contrast imaging simultaneously and it can distinguish the tumors from the normal tissues easily depending on the sensitivity to tumor acidic microenvironments and T 1 -T 2 * dualmodal imaging ability, thereby improving the accuracy of cancer diagnosis. Meanwhile, the minor toxic and side effects of MnSiO 3 @Fe 3 O 4 @C NPs can be neglected, which is different from the harmful Gd-based MR imaging contrast agents. In addition, mesoporous MnSiO 3 can be used as a potential drug carrier for cancer theranostics.
III. CONCLUSION
In summary, we have developed a facile and mild process for mesoporous structured MnSiO 3 @Fe 3 O 4 @C NPs, which possess negligible cytotoxicity with mean size of 120 nm. The monodisperse SiO 2 @Fe 3 O 4 @C precursor were etched using Na 3 
